There is new hope for an effective treatment for people with fibromyalgia, with a research study about to begin at Deakin University Integrated research unit in Victoria. 
Fibromyalgia has been estimated to affect 2 to 4 percent of the population and represents a significant burden on the healthcare system. Whilst the exact cause of fibromyalgia is not known and there is no ‘cure' available as yet, there are a number of treatment options which show promise. This study involves using Cranial Electrotherapy Stimulation (CES), a therapy which has been clinically proven to be effective in managing anxiety, depression, insomnia and pain in the US. In the two years that it has been available in Australia it has shown great promise with results similar to those seen in the US. This therapy involves a mild stimulation of the brain by passing a minute current of electricity into the brain via electrodes clipped to the earlobes. Patients will use the Alpha-Stim SCS device for 1 hour per day over 6 weeks, and the levels of pain, anxiety, depression and quality of sleep will be measured during this time. This treatment is a non-invasive intervention with minimal side effects. Results are expected out towards the end of the year.
For more information or to arrange an interview contact: Press release published by Seeking Media. http://www.seekingmedia.com.au/ |
